Trial intelligence / Profile preview

Fenofibrate Effects on EPCs in Diabetic Retinopathy

NCT01927315Phase 4Completed

Sponsor
Università di Padova
Start
Aug 2013
Primary completion
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of fenofibrate in diabetic retinopathy (DR), sponsored by Università di Padova. Started Aug 2013; status: completed.

02

Drugs

fenofibrate
03

Conditions

diabetic retinopathy (DR)

Beyond the preview

Go deeper on NCT01927315.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01927315.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call